Ibex LTD Form 4 insider transactions

IBEX Ltd's Chief Sales/Marketing Officer, Julie K Casteel, was granted 4,400 restricted stock units, vesting over four years.

IBEX Ltd's Chief Sales and CS Officer, Bruce Neil Dawson, was granted 3,250 restricted stock units, vesting over four years.

IBEX Ltd's Chief Legal Officer, Christina Alice Trofimuk-O'Connor, was granted 4,400 restricted stock units, aligning her interests with shareholders.

IBEX Ltd's Chief People Officer, Paul Joseph Inson, was granted 4,000 restricted stock units, vesting over four years.

IBEX Ltd's Chief AI & Digital Officer, Michael Joseph Darwal, reported a non-discretionary transfer of 925 common shares at $28.39 per share due to a divorce settlement.

IBEX Ltd's CEO, Robert Thomas Dechant, sold 6,000 common shares for a weighted average price of $28.4588 per share under a pre-arranged 10b5-1 plan.

IBEX Chief Sales/Marketing Officer Julie K. Casteel reported the vesting of performance-based restricted stock and subsequent tax-related share disposition.

IBEX Ltd's Chief Legal Officer, Christina Trofimuk-O'Connor, reported the vesting of performance-based restricted stock and subsequent tax-related share withholding.

IBEX Ltd's Chief Operating Officer, David Martin Afdahl, received 109,708 common shares as a restricted stock award tied to performance targets, with a portion withheld for taxes.

IBEX Ltd.'s Chief Financial Officer, Taylor C. Greenwald, received a restricted stock award of 20,000 common shares, with a portion vesting on February 6, 2026, and shares withheld for tax purposes.

IBEX Ltd's Chief AI & Digital Officer, Michael Joseph Darwal, increased his beneficial ownership through RSU grants and performance share vesting, while also selling shares for tax purposes.

IBEX Ltd's CEO, Robert Thomas Dechant, saw a portion of his performance-based restricted stock award vest after the company met revenue and EBITDA targets.

IBEX Chief Sales and CS Officer Bruce Neil Dawson reported the vesting of performance-based restricted stock and subsequent tax-related share disposition.

IBEX Ltd's Chief People Officer, Paul Joseph Inson, reported the vesting of performance-based restricted stock and a related tax withholding transaction.

IBEX Ltd. Director Daniella Ballou-Aares exercised 2,066 stock options at $19 per share, increasing her direct beneficial ownership to 15,060 common shares.

IBEX Ltd's CEO, Robert Thomas Dechant, filed an amended Form 4 to correct an omission regarding the exercise of 45,027 stock options at $19 per share.

IBEX Ltd's Chief Technology Officer, Michael Ringman, was granted 15,000 Restricted Stock Units, vesting over several years.

IBEX Chief People Officer Paul Joseph Inson reported the acquisition of 2,347 common shares from vested performance units and the subsequent sale of 697 shares to cover tax obligations.

IBEX Ltd's Chief Legal Officer, Christina Alice Trofimuk-O'Connor, acquired 3,228 common shares from vested performance units and subsequently sold 1,001 shares to cover tax obligations.

IBEX Chief Sales and CS Officer, Bruce Neil Dawson, reported the acquisition of shares from vested performance units and subsequent sale to cover tax obligations.

IBEX Chief Sales/Marketing Officer Julie K Casteel sold 806 common shares to cover tax withholding obligations after earning 3,228 performance-based stock units.

IBEX Ltd.'s Chief Operating Officer, David Martin Afdahl, acquired 3,228 common shares from vested performance units and subsequently sold 1,103 shares to cover tax withholding obligations.

IBEX Ltd.'s Chief Financial Officer, Taylor C. Greenwald, acquired 4,196 common shares through performance-based units and subsequently sold 1,275 shares to cover tax obligations.

IBEX CEO Robert Thomas Dechant reported the acquisition of performance-based stock units and subsequent sale of shares to cover tax obligations.

IBEX Ltd's Chief Financial Officer, Taylor C Greenwald, sold 2,295 common shares at $40.7302 each to cover tax withholding obligations from restricted stock unit vesting.

IBEX Chief Sales/Marketing Officer Julie K Casteel sold 5,000 common shares on September 16, 2025, at $39.0002 per share, reducing her direct beneficial ownership to 25,895 shares.

IBEX Ltd's Chief Sales and CS Officer, Bruce Neil Dawson, sold 8,879 common shares on September 16, 2025, following an acquisition of 8,114 shares, all executed under a Rule 10b5-1 plan.

IBEX Ltd's CEO, Robert Thomas Dechant, executed a pre-planned transaction, exercising options for 45,027 common shares at $19 and subsequently selling them at $38.89.

IBEX Ltd's Chief Legal Officer, Christina Alice Trofimuk-O'Connor, reported the sale of 844 common shares at $38.5 per share on September 16, 2025, executed under a Rule 10b5-1 plan.

IBEX Ltd's Chief Financial Officer, Taylor C Greenwald, sold 438 common shares at $29.13 each to cover tax withholding obligations related to restricted stock unit vesting.